Malaysia cracks down on e-cigarette products containing illicit substances

Feb.24

Over 100 cases of e-cigarette products suspected of containing drugs were investigated in Malaysia in the past two years.

According to a report from NST on February 23rd, Malaysia has initiated over 100 investigations over the past two years into e-cigarette products allegedly containing illicit substances.

Malaysia's Deputy Health Minister Lukanisman Awang Sauni announced that with the passing of the "2024 Public Health Tobacco Control Act" (Act 852), all products related to cigarettes and e-cigarettes must be registered and labeled.

According to records, we launched 32 investigations in 2023, which increased to 90 in 2024. These investigations primarily targeted drugs and products containing substances related to drugs.

Last week, a state legislator called for action to curb adolescent addiction to "magic mushroom" e-cigarette products (related reading: Malaysia's e-cigarette sales go underground: online sales still rampant, brand searches are key). However, a deputy minister stated that no hallucinogenic compound psilocybin was found in the tested samples of "magic mushroom.

He added that they are strengthening law enforcement cooperation with relevant departments, including the police. Due to the increasingly complex sales methods, they are also monitoring on social media platforms.

References:

[1] Over 100 cases of drug-laced vapes under probe, says deputy minister

Also Read:

[1] Regulating E-cigarette Sales: The Importance of Control and Support

[2] E-cigarette Industry in Malaysia Urges Enforcement of Public Health Law

[3] Malaysia Health Ministry Prepares to Reconsider Full E-Cigarette Ban

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Jinjia Venture Faces New Judicial Auction, Control Unchanged

Jinjia Group said its controlling shareholder, Jinjia Venture, will have part of its holdings auctioned by the Shenzhen Nanshan Court, involving 43.4 million shares. Earlier, the Shenzhen Intermediate Court announced another auction of 37.27 million shares. Together they represent 5.56% of total equity. Jinjia said the auctions will not affect company control.

Oct.23 by 2FIRSTS.ai

Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders

Social media users reported purchasing Altria’s new nicotine pouch, on!PLUS, in the United States. 2Firsts found that the official on! website had temporarily opened online purchase and store locator functions. The product has not received FDA authorization. Around the same time, British American Tobacco (BAT) suspended its unlicensed Vuse One vape launch in the U.S. amid regulatory pressure.

Oct.28 by 2FIRSTS.ai

South Korea Implements Law Requiring Full Disclosure of Tobacco Harmful Substances

South Korea has enacted the Tobacco Harm Management Act, effective November 1, 2025, requiring tobacco manufacturers and importers to test and report harmful substances in their products every two years. Results for all tobacco types—including combustible cigarettes, heated tobacco, and e-cigarettes—will be publicly available from mid-2026.

Nov.04 by 2FIRSTS.ai

PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales

PMI reported strong third-quarter 2025 results, underscoring the continued success of its smoke-free transformation. Net revenues rose 9.4% year-over-year to $10.85 billion, driven by robust growth in the smoke-free segment, which now accounts for 41% of total net revenues and over 42% of gross profit.Despite a 3.2% decline in cigarette shipments, combustible revenues climbed 4.3% thanks to strong pricing.